Radient Pharmaceuticals (RPC) Reports Q1 Loss of $0.13, Revenue Falls Y/Y
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Radient Pharmaceuticals (NYSE: RPC) | Delayed: 9.40 -0.21 (2.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.61 | 52 Week High | $1.69 | |||
| Open | $9.65 | 52 Week Low | $0.14 | |||
| Day High | $9.71 | P/E | N/A | |||
| Day Low | $9.29 | EPS | $-3.02 | |||
| Volume | 602,562 | |||||
